Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells

BackgroundStanniocalcin-1(STC-1) is up-regulated in several cancers including gastric cancer. Evidences suggest that STC-1 is associated with carcinogenesis and angiogenic process. However, it is unclear on the exact role for STC-1 in inducing angiogenesis and tumorigeneisis.MethodBGC/STC cells (high-expression of STC-1) and BGC/shSTC cells (low- expression of STC-1) were constructed to investigate the effect of STC-1 on the xenograft tumor growth and angiogenesis in vitro and in vivo. ELISA assay was used to detect the expression of vascular endothelial growth factor (VEGF) in the supernatants. Neutralizing antibody was used to inhibit VEGF expression in supernatants. The expression of phosphorylated -PKCβII, phosphorylated -ERK1/2 and phosphorylated -P38 in the BGC treated with STC-1protein was detected by western blot.ResultsSTC-1 could promote angiogenesis in vitro and in vivo, and the angiogenesis was consistent with VEGF expression in vitro. Inhibition of VEGF expression in supernatants with neutralizing antibody markedly abolished angiogenesis induced by STC-1 in vitro. The process of STC-1-regulated VEGF expression was mediated via PKCβII and ERK1/2.ConclusionsSTC-1 promotes the expression of VEGF depended on the activation of PKCβII and ERK1/2 pathways. VEGF subsequently enhances tumor angiogenesis which in turn promotes the gastric tumor growth.

[1]  M. King,et al.  BRCA1 transcriptionally regulates genes involved in breast tumorigenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Andersson,et al.  Hypoxic Preconditioning Induces Neuroprotective Stanniocalcin-1 in Brain via IL-6 Signaling , 2007, Stroke.

[3]  Matthew R. McReynolds,et al.  Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes. , 2007, American journal of physiology. Renal physiology.

[4]  Franklin Peale,et al.  In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set. , 2002, Physiological genomics.

[5]  G. F. Wagner,et al.  Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation. , 2005, American journal of physiology. Endocrinology and metabolism.

[6]  T. Morimoto,et al.  Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. , 2006, International journal of oncology.

[7]  F. Grasselli,et al.  Stanniocalcin, a Potential Ovarian Angiogenesis Regulator, Does Not Affect Endothelial Cell Apoptosis , 2009, Annals of the New York Academy of Sciences.

[8]  Zhongxin Lu,et al.  STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. , 2010, European journal of cancer.

[9]  F. Grasselli,et al.  Stanniocalcin 1 is a potential physiological modulator of steroidogenesis in the swine ovarian follicle , 2009, Veterinary Research Communications.

[10]  R. Bast,et al.  Stanniocalcin 1 and ovarian tumorigenesis. , 2010, Journal of the National Cancer Institute.

[11]  Qi Wang,et al.  gamma-Tocotrienol modulates the paracrine secretion of VEGF induced by cobalt(II) chloride via ERK signaling pathway in gastric adenocarcinoma SGC-7901 cell line. , 2010, Toxicology.

[12]  J. Pouysségur,et al.  Implication of the ERK pathway on the post-transcriptional regulation of VEGF mRNA stability. , 2010, Methods in molecular biology.

[13]  J. Folkman,et al.  Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.

[14]  U. Förstermann,et al.  Protein kinase C α promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor , 2008 .

[15]  G. F. Wagner,et al.  Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. , 2005, Endocrinology.

[16]  Jingxia Li,et al.  Essential role of PI-3K, ERKs and calcium signal pathways in nickel-induced VEGF expression , 2005, Molecular and Cellular Biochemistry.

[17]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[18]  G. F. Wagner,et al.  Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice. , 2002, Endocrinology.

[19]  S. Brem,et al.  Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier. , 1988, The American journal of pathology.

[20]  A. Giuliano,et al.  Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  Y. Yoshiko,et al.  Stanniocalcin 1 Acts as a Paracrine Regulator of Growth Plate Chondrogenesis* , 2006, Journal of Biological Chemistry.

[22]  D. Jong,et al.  A novel human cDNA highly homologous to the fish hormone stanniocalcin , 1995, Molecular and Cellular Endocrinology.

[23]  A. Hart,et al.  PKC‐1 acts with the ERK MAPK signaling pathway to regulate Caenorhabditis elegans mechanosensory response , 2011, Genes, brain, and behavior.

[24]  F. Otto,et al.  Gene deregulation in gastric cancer. , 2005, Gene.

[25]  I. Zachary,et al.  Vascular endothelial growth factor regulates stanniocalcin-1 expression via neuropilin-1-dependent regulation of KDR and synergism with fibroblast growth factor-2. , 2008, Cellular signalling.

[26]  S. Govoni,et al.  PKCbetaII/HuR/VEGF: A new molecular cascade in retinal pericytes for the regulation of VEGF gene expression. , 2008, Pharmacological research.

[27]  J. Aubin,et al.  Stanniocalcin 1 stimulates osteoblast differentiation in rat calvaria cell cultures. , 2003, Endocrinology.

[28]  R. Klopfleisch,et al.  Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. , 2009, Journal of comparative pathology.

[29]  I. Zachary,et al.  Vascular Endothelial Growth Factor–Regulated Gene Expression in Endothelial Cells: KDR-Mediated Induction of Egr3 and the Related Nuclear Receptors Nur77, Nurr1, and Nor1 , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[30]  M. Cornianu,et al.  Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[31]  Yayi Hou,et al.  The expression and location of midkine in gastric carcinomas of Chinese patients. , 2007, Cellular & molecular immunology.

[32]  R. Reddel,et al.  Mammalian stanniocalcins and cancer. , 2003, Endocrine-related cancer.

[33]  U. Förstermann,et al.  Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. , 2008, Cardiovascular research.

[34]  Yayi Hou,et al.  siRNA targeting midkine inhibits gastric cancer cells growth and induces apoptosis involved caspase-3,8,9 activation and mitochondrial depolarization. , 2007, Journal of biomedical science.

[35]  M. Monden,et al.  Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. , 2000, International journal of oncology.